Bioorganic and Medicinal Chemistry Letters p. 1019 - 1022 (1998)
Update date:2022-08-05
Topics:
Sasaki, Shigeki
Hashimoto, Tomohiro
Obana, Norihiro
Yasuda, Hideyo
Uehara, Yoshimasa
Maeda, Minoru
New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.
View MoreLianYunGang Chiral Chemical(CHINA) CO.,LTD
Contact:+86-518-83616958 +86-519-82884848
Address:LianYunGang Chemical Industry Park (JiangSu)
Jiangsu Cale New Material Co.ltd
Contact:+86-515-88334667/88203550
Address:Zhongshan 3rd Road, Coastal Chemical Industry Park, Yancheng, Jiangsu, China
Chongqing Shuangfeng Chemical Co.,Ltd
Contact:+86-23-49850156
Address:No.663,xuanhua Rd,yongchuan,chongqing,China
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Jiacheng-Chem Enterprises Limited
Contact:86-571-86711508
Address:19 Floor, CIBC Holley International Building, No. 198,Wuxing Road, Hangzhou, China,310020
Doi:10.1021/ic020375g
(2002)Doi:10.1016/S0277-5387(97)00376-8
(1998)Doi:10.1016/S0040-4039(00)72793-6
(1968)Doi:10.1016/S0040-4039(00)71266-4
(1991)Doi:10.1039/j39680002947
(1968)Doi:10.1016/S0957-4166(97)00128-6
(1997)